942 related articles for article (PubMed ID: 22621925)
1. Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways.
Sears CR; Turchi JJ
J Biol Chem; 2012 Jul; 287(29):24263-72. PubMed ID: 22621925
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.
Sears CR; Cooney SA; Chin-Sinex H; Mendonca MS; Turchi JJ
DNA Repair (Amst); 2016 Apr; 40():35-46. PubMed ID: 26991853
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining.
Boeckman HJ; Trego KS; Turchi JJ
Mol Cancer Res; 2005 May; 3(5):277-85. PubMed ID: 15886299
[TBL] [Abstract][Full Text] [Related]
4. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
[TBL] [Abstract][Full Text] [Related]
5. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining.
Kriegs M; Kasten-Pisula U; Rieckmann T; Holst K; Saker J; Dahm-Daphi J; Dikomey E
DNA Repair (Amst); 2010 Aug; 9(8):889-97. PubMed ID: 20615764
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining.
Bergs JW; Krawczyk PM; Borovski T; ten Cate R; Rodermond HM; Stap J; Medema JP; Haveman J; Essers J; van Bree C; Stalpers LJ; Kanaar R; Aten JA; Franken NA
DNA Repair (Amst); 2013 Jan; 12(1):38-45. PubMed ID: 23237939
[TBL] [Abstract][Full Text] [Related]
7. SIRT6 is a DNA double-strand break sensor.
Onn L; Portillo M; Ilic S; Cleitman G; Stein D; Kaluski S; Shirat I; Slobodnik Z; Einav M; Erdel F; Akabayov B; Toiber D
Elife; 2020 Jan; 9():. PubMed ID: 31995034
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors.
Macieja A; Kopa P; Galita G; Pastwa E; Majsterek I; Poplawski T
Mol Biol Rep; 2019 Aug; 46(4):3625-3636. PubMed ID: 31020489
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-Induced Double-Strand Break Repair in Arabidopsis Nonhomologous End-Joining Mutants.
Shen H; Strunks GD; Klemann BJ; Hooykaas PJ; de Pater S
G3 (Bethesda); 2017 Jan; 7(1):193-202. PubMed ID: 27866150
[TBL] [Abstract][Full Text] [Related]
10. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
Murmann-Konda T; Soni A; Stuschke M; Iliakis G
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
[TBL] [Abstract][Full Text] [Related]
11. Roles for the DNA-PK complex and 53BP1 in protecting ends from resection during DNA double-strand break repair.
Shibata A; Jeggo PA
J Radiat Res; 2020 Sep; 61(5):718-726. PubMed ID: 32779701
[TBL] [Abstract][Full Text] [Related]
12. Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells.
Pastwa E; Poplawski T; Lewandowska U; Somiari SB; Blasiak J; Somiari RI
Int J Biochem Cell Biol; 2014 Aug; 53():423-31. PubMed ID: 24953561
[TBL] [Abstract][Full Text] [Related]
13. Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment.
Al-Aamri HM; Irving HR; Meehan-Andrews T; Bradley C
BMC Res Notes; 2019 Sep; 12(1):625. PubMed ID: 31551083
[TBL] [Abstract][Full Text] [Related]
14. Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways.
Mladenov E; Iliakis G
Mutat Res; 2011 Jun; 711(1-2):61-72. PubMed ID: 21329706
[TBL] [Abstract][Full Text] [Related]
15. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
Guan J; Zhao Q; Mao W
Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
[TBL] [Abstract][Full Text] [Related]
16. Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination.
Karimi-Busheri F; Rasouli-Nia A; Allalunis-Turner J; Weinfeld M
Cancer Res; 2007 Jul; 67(14):6619-25. PubMed ID: 17638872
[TBL] [Abstract][Full Text] [Related]
17. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
Yang S; Wang XQ
BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
[TBL] [Abstract][Full Text] [Related]
18. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
[TBL] [Abstract][Full Text] [Related]
19. Investigations on the role of base excision repair and non-homologous end-joining pathways in sodium selenite-induced toxicity and mutagenicity in Saccharomyces cerevisiae.
Mániková D; Vlasáková D; Loduhová J; Letavayová L; Vigasová D; Krascsenitsová E; Vlcková V; Brozmanová J; Chovanec M
Mutagenesis; 2010 Mar; 25(2):155-62. PubMed ID: 19955329
[TBL] [Abstract][Full Text] [Related]
20. Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin.
Wan Q; Shen Y; Zhao H; Wang B; Zhao L; Zhang Y; Bu X; Wan M; Shen C
J Cell Physiol; 2019 Jul; 234(7):10360-10371. PubMed ID: 30417376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
